Strong FGFR3 staining is a marker for FGFR3 fusions and poor prognosis in diffuse gliomas

被引：0
|
作者：
Granberg, Kirsi J.
Annala, Matti
Lehtinen, Birgitta
Kesseli, Juha
Haapasalo, Joonas
Yli-Harja, Olli
Visakorpi, Tapio
Haapasalo, Hannu
Nykter, Matti
Zhang, Wei
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-5011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5011
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function
    Meyer, April N.
    Modaff, Peggy
    Wang, Clark G.
    Wohler, Elizabeth
    Sobreira, Nara L.
    Donoghue, Daniel J.
    Pauli, Richard M.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2021, 185 (03) : 798 - 805
  • [42] FGFR3, TERT, TP53 mutations and the FGFR3 gene expression in bladder cancer as prognostic markers
    Mikhaylenko, D. S.
    Sergienko, S. A.
    Kuznetsova, E. B.
    Zaborsky, I. N.
    Martynov, M., I
    Loran, O. B.
    Efremov, G. D.
    Samoylova, S. A.
    Alekseev, B. Ya
    Musatova, V. V.
    Bure, I., V
    Nemtsova, M., V
    ONKOUROLOGIYA, 2021, 17 (01): : 89 - 100
  • [43] The Hsp90 inhibitor ganetespib promotes the degradation of FGFR3 in bladder cancer models and induces regression in tumors harboring oncogenic FGFR3 fusions.
    Acquaviva, Jaime L.
    Zhang, Chaohua
    He, Suqin
    Jimenez, John-Paul
    Nagai, Masa
    Sang, Jim
    Sequeira, Manuel
    Smith, Donald L.
    Knowles, Margaret A.
    Proia, David A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [44] FGFR3 and FGFR4 mutational analyses in thyroid carcinoma
    Serra, S.
    Cheng, S.
    Ezzat, S.
    Asa, S. L.
    LABORATORY INVESTIGATION, 2008, 88 : 110A - 111A
  • [45] FGFR3 mutations as novel oncogenic targets
    Cardona, Gabriela Martinez
    Gaffney, Dana
    Bell, Katherine
    Portale, Joseph
    Dunworth, Matthew
    Lorenzi, Matthew
    Platero, Suso
    Karkera, Jayaprakash
    CANCER RESEARCH, 2016, 76
  • [46] FGFR3 dysregulation and clinical outcome in myeloma
    Rasmussen, T
    Hudlebusch, HR
    Knudsen, LM
    Johnsen, HE
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) : 166 - 166
  • [47] Mutation of FGFR3 in transitional cell carcinoma
    Sibley, K
    Kennedy, W
    Knowles, M
    BRITISH JOURNAL OF CANCER, 2001, 85 : 79 - 79
  • [48] FGFR3 pathway identification by oligonucleotide microarrays
    Gomez Roman, Jose Javier
    Entrena, Edurne
    Fernandez, Dietmar
    Ochoa, Gorka
    Osaba, Lourdes
    Luis Gutierrez, Jose
    Fernando Val-Bernal, Jose
    VIRCHOWS ARCHIV, 2008, 452 : S46 - S47
  • [49] Fgfr3 Regulates Development of the Caudal Telencephalon
    Moldrich, Randal X.
    Mezzera, Cecilia
    Holmes, William M.
    Goda, Sailaja
    Brookfield, Sam J.
    Rankin, Alastair J.
    Barr, Emily
    Kurniawan, Nyoman
    Dewar, Deborah
    Richards, Linda J.
    Lopez-Bendito, Guillermina
    Iwata, Tomoko
    DEVELOPMENTAL DYNAMICS, 2011, 240 (06) : 1586 - 1599
  • [50] Replacing cystoscopies with FGFR3 urine assays
    Melanie Clyne
    Nature Reviews Urology, 2013, 10 (1) : 4 - 4
12345